Investigative journalists around the world relied on funding from the U.S. Now, those watchdogs are scrambling to survive a sudden cash crunch.
Related Posts
Kamala Harris Dreams of an ‘Opportunity Economy.’ This Is How to Make It a Reality.
What we can learn from the science of economic opportunity.
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
What Can the Department of Government Efficiency Do?
President-elect Trump has indicated the entity will operate outside the government, a position that comes with legal limits.